Contact this trialFirst, we need to learn more about you.
mTOR Inhibitor
Everolimus + Letrozole or Hormonal Therapy for Endometrial Cancer
Recruiting3 awardsPhase 2
Oklahoma City, Oklahoma
This trial is studying how well two drugs, everolimus and letrozole, work compared to tamoxifen and medroxyprogesterone acetate in treating endometrial cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.